Search for opportunities to participate in a senior health research study.
UT Southwestern Medical Center’s team of researchers and physicians offers the most advanced care for patients with memory disorders (Alzheimer's and dementia). Our services also extend to patients’ families and caregivers, providing education and support at every stage of their journey.
Compassionate, Innovative Care for Memory Disorders
When memory loss affects a person’s daily life, it might be a sign of a degenerative disease or memory disorder. Memory loss can be caused by many conditions, and it’s important to seek care to help manage symptoms and improve quality of life.
Alzheimer’s disease is the best-known degenerative brain disorder, and UT Southwestern is at the forefront of research and care for the disease.
Our Alzheimer’s Disease Center is one of only 31 institutions nationwide funded by the National Institute on Aging to evaluate patients and conduct scientific research on the causes of Alzheimer's disease. In addition, UT Southwestern’s Center for Alzheimer’s and Neurodegenerative Diseases, led by Marc Diamond, M.D., uses a multidisciplinary approach to speed the development of effective treatment for neurodegenerative diseases.
Our care staff includes neurologists who specialize in behavioral neurology and neuropsychiatry, an advanced practice professional (APP), a neuropsychologist, and a psychometrist.
In addition to Alzheimer’s disease, memory disorders treated at UT Southwestern include:
- Frontotemporal dementia
- Lewy body disease
- Memory disorders associated with Parkinson’s disease, multiple sclerosis, and Huntington’s disease
- Mild cognitive impairment
- Progressive supranuclear palsy
Patients at UT Southwestern receive thorough diagnostic evaluations to identify and classify any existing cognitive or memory problems or disorders.
We offer the most advanced diagnostics to provide a roadmap for treatment. Our diagnostic tests include:
- Neuropsychological testing
- Magnetic resonance imaging (MRI) scans
- Positron emission tomography (PET) scans
Clinical Trials and Research Breakthroughs
Groundbreaking research at UT Southwestern provides new hope for future treatments. Waxy buildups of cholesterol in the brain are one sign of Alzheimer’s disease. Recent tests involving cholesterol-reducing drugs showed that the medications are effective at lowering cholesterol levels in the brain. This discovery might lead to new ways to fight the debilitating effects of the disorder.
Our Cell Biology Department has also made important strides in understanding the disease. Researchers have isolated the portion of an enzyme that produces a particular protein that leads to Alzheimer’s. Now that the specific section has been pinpointed, researchers might be able to develop treatments that target this section and block the protein’s production.
January 8, 2020
Showing 3 locations
Richardson, Texas 75080 972-669-7195
Dallas, Texas 75390 214-645-8650